These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9144876)

  • 1. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
    Wikström P; Bergh A; Damber JE
    Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
    Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
    Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of gonadotropin-releasing hormone receptor mRNA in the rat ventral prostate and dunning R3327 PAP adenocarcinoma before and after castration.
    Tieva A; Wilkström P; Olofsson JI; Bergh A; Damber JE
    Prostate; 1999 May; 39(2):101-7. PubMed ID: 10221565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration.
    Häggström S; Wikström P; Bergh A; Damber JE
    Prostate; 1998 Jul; 36(2):71-9. PubMed ID: 9655258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
    Guo Y; Jacobs SC; Kyprianou N
    Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration.
    Brodin G; ten Dijke P; Funa K; Heldin CH; Landström M
    Cancer Res; 1999 Jun; 59(11):2731-8. PubMed ID: 10363999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis.
    Hanada K; Solchaga LA; Caplan AI; Hering TM; Goldberg VM; Yoo JU; Johnstone B
    J Cell Biochem; 2001 Mar; 81(2):284-94. PubMed ID: 11241668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
    Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression.
    Kim IY; Ahn HJ; Zelner DJ; Park L; Sensibar JA; Lee C
    Mol Endocrinol; 1996 Jan; 10(1):107-15. PubMed ID: 8838150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.
    Kundu SD; Kim IY; Yang T; Doglio L; Lang S; Zhang X; Buttyan R; Kim SJ; Chang J; Cai X; Wang Z; Lee C
    Prostate; 2000 May; 43(2):118-24. PubMed ID: 10754527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
    Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
    Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
    Wong YC; Xie W; Tsao SW
    Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.